(EXEL) Exelixis - Performance 58.7% in 12m
Compare EXEL with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
52.41%
#11 in Group
Rel. Strength
92.12%
#603 in Universe
Total Return 12m
58.70%
#22 in Group
Total Return 5y
109.62%
#24 in Group
P/E 20.9
61th Percentile in Group
P/E Forward 17.9
65th Percentile in Group
PEG 2.27
87th Percentile in Group
FCF Yield 6.97%
94th Percentile in Group
12m Total Return: EXEL (58.7%) vs XBI (-11%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| ABBV NYSE AbbVie |
-2.97% | 17.7% | 234% | 84.1 | 16.4 | 0.42 | -49.6% | -19% |
| UTHR NASDAQ United Therapeutics |
0.72% | 36.6% | 226% | 13 | 11.3 | 1.43 | 83.8% | 78.5% |
| HLN NYSE Haleon |
-3.97% | 23.4% | 39.7% | 25.6 | 20.9 | 1.85 | -38.6% | -24.4% |
| AMGN NASDAQ Amgen |
-1.63% | 14.1% | 68.5% | 40.5 | 14.8 | 1.04 | -18.8% | -20% |
| LONN SW Lonza |
-7.89% | 0.58% | 37% | 60.5 | 31.8 | 1.16 | 12.6% | -10.3% |
| NBIX NASDAQ Neurocrine Biosciences |
-5.39% | -21.4% | 18.7% | 33.6 | 22.8 | 0.27 | 61.5% | 31.6% |
| BIM PA Biomerieux |
1.3% | 15.8% | 12.1% | 31.4 | 25.8 | 1.47 | -47.6% | -26.9% |
| KMDA NASDAQ Kamada |
1.65% | 24.1% | 14.1% | 27 | 25 | 1 | 58.7% | 15% |
Performance Comparison: EXEL vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for EXEL
| Total Return (including Dividends) | EXEL | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | -3.92% | -5.85% | -3.01% |
| 3 Months | 9.13% | -11.95% | -3.15% |
| 12 Months | 58.70% | -11.00% | 10.19% |
| 5 Years | 109.62% | 0.65% | 129.24% |
| Trend Score (consistency of price movement) | EXEL | XBI | S&P 500 |
| 1 Month | -49.5% | -59.8% | -5.5% |
| 3 Months | 63.0% | -70.5% | -58.4% |
| 12 Months | 90.8% | -6.9% | 84.1% |
| 5 Years | 22.7% | -50% | 84.4% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #66 | 2.05% | -0.94% |
| 3 Month | #28 | 23.9% | 12.7% |
| 12 Month | #21 | 78.3% | 44.0% |
| 5 Years | #25 | 108% | -8.56% |
FAQs
Does EXEL Exelixis outperforms the market?
Yes,
over the last 12 months EXEL made 58.70%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.00%.
Over the last 3 months EXEL made 9.13%, while XBI made -11.95%.
Over the last 3 months EXEL made 9.13%, while XBI made -11.95%.
Performance Comparison EXEL vs Indeces and Sectors
EXEL vs. Indices EXEL is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 0.80% | -0.91% | 39.9% | 48.5% |
| US NASDAQ 100 | QQQ | 1.78% | 0.14% | 40.7% | 50.1% |
| US Dow Jones Industrial 30 | DIA | 0.60% | -1.78% | 39.0% | 49.2% |
| German DAX 40 | DAX | 2.10% | -0.54% | 23.1% | 37.0% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 1.09% | -4.15% | 55.1% | 49.6% |
| Hongkong Hang Seng | HSI | -1.17% | -6.69% | 49.1% | 41.4% |
| India NIFTY 50 | INDA | -0.23% | -11.8% | 50.3% | 58.0% |
| Brasil Bovespa | EWZ | 0.69% | -12.2% | 47.9% | 70.4% |
EXEL vs. Sectors EXEL is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 2.34% | -0.11% | 31.8% | 39.5% |
| Consumer Discretionary | XLY | 0.04% | -0.09% | 36.5% | 44.6% |
| Consumer Staples | XLP | -1.99% | -2.08% | 39.1% | 47.7% |
| Energy | XLE | -0.29% | -11.9% | 34.3% | 57.9% |
| Financial | XLF | 0.32% | -1.22% | 27.7% | 36.5% |
| Health Care | XLV | 0.38% | -0.76% | 44.6% | 57.0% |
| Industrial | XLI | 0.49% | -3.23% | 40.6% | 50.2% |
| Materials | XLB | -0.30% | -4.43% | 48.0% | 62.6% |
| Real Estate | XLRE | -1.24% | -1.23% | 43.0% | 45.3% |
| Technology | XLK | 1.93% | 0.09% | 45.0% | 56.7% |
| Utilities | XLU | -2.49% | -4.74% | 40.8% | 33.5% |
| Aerospace & Defense | XAR | 1.40% | -5.20% | 36.0% | 37.8% |
| Biotech | XBI | 5.36% | 1.93% | 57.6% | 69.7% |
| Homebuilder | XHB | 0.30% | -4.07% | 59.3% | 66.4% |
| Retail | XRT | -1.50% | -3.42% | 44.0% | 63.5% |